S100A10 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	45 studies	65% ± 25%	Explore
macrophage	42 studies	56% ± 27%	Explore
fibroblast	42 studies	57% ± 25%	Explore
natural killer cell	40 studies	57% ± 17%	Explore
CD8-positive, alpha-beta T cell	38 studies	60% ± 19%	Explore
T cell	36 studies	56% ± 22%	Explore
CD4-positive, alpha-beta T cell	35 studies	57% ± 23%	Explore
B cell	33 studies	33% ± 10%	Explore
conventional dendritic cell	32 studies	81% ± 17%	Explore
endothelial cell of lymphatic vessel	29 studies	81% ± 24%	Explore
classical monocyte	29 studies	86% ± 14%	Explore
dendritic cell	28 studies	73% ± 24%	Explore
monocyte	28 studies	66% ± 24%	Explore
regulatory T cell	27 studies	65% ± 21%	Explore
non-classical monocyte	26 studies	85% ± 12%	Explore
epithelial cell	26 studies	77% ± 22%	Explore
mature NK T cell	24 studies	57% ± 21%	Explore
pericyte	24 studies	34% ± 17%	Explore
basal cell	22 studies	69% ± 19%	Explore
smooth muscle cell	21 studies	34% ± 17%	Explore
mast cell	20 studies	46% ± 15%	Explore
memory B cell	20 studies	40% ± 15%	Explore
ciliated cell	19 studies	62% ± 21%	Explore
gamma-delta T cell	19 studies	63% ± 18%	Explore
plasmacytoid dendritic cell	19 studies	39% ± 15%	Explore
plasma cell	17 studies	40% ± 16%	Explore
naive B cell	17 studies	26% ± 9%	Explore
capillary endothelial cell	17 studies	65% ± 22%	Explore
CD16-negative, CD56-bright natural killer cell, human	16 studies	54% ± 18%	Explore
mucosal invariant T cell	16 studies	63% ± 20%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	55% ± 18%	Explore
connective tissue cell	16 studies	53% ± 22%	Explore
myeloid cell	16 studies	57% ± 29%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	58% ± 18%	Explore
vein endothelial cell	15 studies	70% ± 26%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	14 studies	62% ± 22%	Explore
endothelial cell of artery	14 studies	70% ± 12%	Explore
endothelial cell of vascular tree	14 studies	67% ± 26%	Explore
type I pneumocyte	12 studies	77% ± 27%	Explore
effector memory CD8-positive, alpha-beta T cell	12 studies	62% ± 23%	Explore
CD4-positive, alpha-beta memory T cell	12 studies	70% ± 22%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	69% ± 17%	Explore
secretory cell	12 studies	72% ± 22%	Explore
mesothelial cell	12 studies	73% ± 21%	Explore
plasmablast	11 studies	52% ± 24%	Explore
abnormal cell	11 studies	47% ± 28%	Explore
myofibroblast cell	11 studies	53% ± 21%	Explore
type II pneumocyte	10 studies	63% ± 25%	Explore
innate lymphoid cell	10 studies	64% ± 20%	Explore
goblet cell	10 studies	72% ± 21%	Explore
neutrophil	9 studies	37% ± 17%	Explore
enterocyte	9 studies	75% ± 27%	Explore
alveolar macrophage	8 studies	70% ± 33%	Explore
club cell	8 studies	52% ± 27%	Explore
effector CD8-positive, alpha-beta T cell	8 studies	71% ± 28%	Explore
leukocyte	8 studies	61% ± 20%	Explore
platelet	7 studies	45% ± 26%	Explore
epithelial cell of proximal tubule	7 studies	48% ± 25%	Explore
progenitor cell	7 studies	82% ± 27%	Explore
CD4-positive helper T cell	6 studies	66% ± 21%	Explore
respiratory goblet cell	6 studies	49% ± 14%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	85% ± 13%	Explore
mononuclear phagocyte	6 studies	72% ± 20%	Explore
kidney loop of Henle epithelial cell	6 studies	76% ± 14%	Explore
glial cell	6 studies	55% ± 26%	Explore
T follicular helper cell	6 studies	41% ± 19%	Explore
intermediate monocyte	6 studies	83% ± 20%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	83% ± 7%	Explore
CD4-positive, alpha-beta cytotoxic T cell	5 studies	63% ± 29%	Explore
central memory CD8-positive, alpha-beta T cell	5 studies	67% ± 19%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	68% ± 19%	Explore
exhausted T cell	5 studies	57% ± 21%	Explore
monocyte-derived dendritic cell	5 studies	86% ± 15%	Explore
astrocyte	5 studies	39% ± 14%	Explore
renal alpha-intercalated cell	5 studies	89% ± 2%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	64% ± 22%	Explore
enteroendocrine cell	5 studies	81% ± 18%	Explore
transit amplifying cell	5 studies	79% ± 18%	Explore
retinal ganglion cell	5 studies	61% ± 25%	Explore
T-helper 17 cell	5 studies	70% ± 18%	Explore
inflammatory macrophage	5 studies	54% ± 15%	Explore
keratinocyte	5 studies	71% ± 28%	Explore
melanocyte	5 studies	88% ± 14%	Explore
erythrocyte	5 studies	39% ± 19%	Explore
hematopoietic precursor cell	4 studies	36% ± 11%	Explore
deuterosomal cell	4 studies	58% ± 12%	Explore
duct epithelial cell	4 studies	53% ± 20%	Explore
squamous epithelial cell	4 studies	68% ± 21%	Explore
pancreatic A cell	4 studies	41% ± 25%	Explore
endothelial cell of sinusoid	4 studies	55% ± 29%	Explore
glomerular endothelial cell	4 studies	53% ± 14%	Explore
intestinal crypt stem cell	4 studies	89% ± 5%	Explore
lymphocyte	4 studies	82% ± 13%	Explore
brush cell	4 studies	47% ± 9%	Explore
Schwann cell	4 studies	64% ± 26%	Explore
adventitial cell	4 studies	81% ± 14%	Explore
double negative thymocyte	4 studies	84% ± 5%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	66% ± 12%	Explore
granulocyte	4 studies	57% ± 4%	Explore
hepatocyte	4 studies	48% ± 23%	Explore
group 3 innate lymphoid cell	4 studies	46% ± 5%	Explore
hematopoietic stem cell	4 studies	28% ± 8%	Explore
Langerhans cell	3 studies	84% ± 17%	Explore
ionocyte	3 studies	44% ± 18%	Explore
kidney connecting tubule epithelial cell	3 studies	75% ± 10%	Explore
renal principal cell	3 studies	80% ± 5%	Explore
extravillous trophoblast	3 studies	78% ± 8%	Explore
placental villous trophoblast	3 studies	73% ± 17%	Explore
neuroendocrine cell	3 studies	52% ± 20%	Explore
tissue-resident macrophage	3 studies	41% ± 21%	Explore
intraepithelial lymphocyte	3 studies	49% ± 6%	Explore
muscle cell	3 studies	27% ± 0%	Explore
germinal center B cell	3 studies	46% ± 11%	Explore
IgA plasma cell	3 studies	45% ± 10%	Explore
adipocyte	3 studies	23% ± 5%	Explore
myoepithelial cell	3 studies	77% ± 16%	Explore
neuron	3 studies	31% ± 12%	Explore
luminal cell of prostate epithelium	3 studies	83% ± 2%	Explore
pancreatic ductal cell	3 studies	90% ± 5%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	41% ± 13%	Explore
T-helper 1 cell	3 studies	86% ± 7%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	80% ± 5%	Explore
double-positive, alpha-beta thymocyte	3 studies	61% ± 30%	Explore
progenitor cell of mammary luminal epithelium	3 studies	57% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	21 studies	66% ± 17%	Explore
lung	19 studies	62% ± 18%	Explore
intestine	13 studies	53% ± 20%	Explore
kidney	9 studies	49% ± 20%	Explore
lymph node	7 studies	39% ± 23%	Explore
uterus	6 studies	54% ± 15%	Explore
liver	6 studies	46% ± 19%	Explore
pancreas	5 studies	35% ± 13%	Explore
eye	5 studies	28% ± 16%	Explore
bone marrow	5 studies	47% ± 19%	Explore
placenta	5 studies	54% ± 27%	Explore
esophagus	4 studies	67% ± 16%	Explore
prostate	4 studies	67% ± 17%	Explore
skin	4 studies	71% ± 24%	Explore
breast	4 studies	67% ± 4%	Explore
brain	3 studies	35% ± 16%	Explore
ovary	3 studies	48% ± 6%	Explore
heart	3 studies	27% ± 7%	Explore
adrenal gland	3 studies	44% ± 14%	Explore
adipose	3 studies	40% ± 19%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	22447.35	1444 / 1445	99%	1692.17	182 / 183
lung	100%	18530.67	577 / 578	98%	1416.62	1137 / 1155
intestine	99%	11159.43	952 / 966	100%	1498.54	525 / 527
kidney	100%	10670.78	89 / 89	96%	963.21	866 / 901
skin	100%	13868.85	1809 / 1809	96%	853.09	451 / 472
breast	100%	15278.71	458 / 459	90%	645.97	1009 / 1118
bladder	100%	10168.14	21 / 21	88%	1245.38	446 / 504
ovary	100%	6461.45	180 / 180	87%	593.38	374 / 430
uterus	85%	4979.01	144 / 170	94%	1331.37	433 / 459
stomach	79%	4073.81	285 / 359	99%	1451.28	282 / 286
prostate	91%	4892.49	224 / 245	71%	336.49	357 / 502
thymus	88%	4303.29	573 / 653	72%	426.60	433 / 605
adrenal gland	99%	10546.16	256 / 258	39%	216.57	89 / 230
pancreas	39%	1578.92	128 / 328	96%	1738.10	171 / 178
liver	31%	1609.79	71 / 226	77%	446.08	312 / 406
adipose	100%	20662.00	1204 / 1204	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	1207.29	44 / 45
heart	95%	6245.05	814 / 861	0%	0	0 / 0
blood vessel	91%	6537.49	1219 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	90%	401.23	26 / 29
peripheral blood	78%	6396.41	726 / 929	0%	0	0 / 0
brain	20%	837.31	519 / 2642	52%	333.84	368 / 705
spleen	71%	2720.87	171 / 241	0%	0	0 / 0
eye	0%	0	0 / 0	38%	102.71	30 / 80
muscle	20%	892.36	164 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0072659	Biological process	protein localization to plasma membrane
GO_0010756	Biological process	positive regulation of plasminogen activation
GO_0043547	Biological process	positive regulation of GTPase activity
GO_0051496	Biological process	positive regulation of stress fiber assembly
GO_1905686	Biological process	positive regulation of plasma membrane repair
GO_0051894	Biological process	positive regulation of focal adhesion assembly
GO_0006900	Biological process	vesicle budding from membrane
GO_0042789	Biological process	mRNA transcription by RNA polymerase II
GO_1900026	Biological process	positive regulation of substrate adhesion-dependent cell spreading
GO_0050767	Biological process	regulation of neurogenesis
GO_0045921	Biological process	positive regulation of exocytosis
GO_0001765	Biological process	membrane raft assembly
GO_0045944	Biological process	positive regulation of transcription by RNA polymerase II
GO_0005615	Cellular component	extracellular space
GO_0005576	Cellular component	extracellular region
GO_0005886	Cellular component	plasma membrane
GO_0045121	Cellular component	membrane raft
GO_0070062	Cellular component	extracellular exosome
GO_0062023	Cellular component	collagen-containing extracellular matrix
GO_0016363	Cellular component	nuclear matrix
GO_0009986	Cellular component	cell surface
GO_0090575	Cellular component	RNA polymerase II transcription regulator complex
GO_0098797	Cellular component	plasma membrane protein complex
GO_0005737	Cellular component	cytoplasm
GO_1990665	Cellular component	AnxA2-p11 complex
GO_0042803	Molecular function	protein homodimerization activity
GO_0008289	Molecular function	lipid binding
GO_0048306	Molecular function	calcium-dependent protein binding
GO_0044325	Molecular function	transmembrane transporter binding
GO_0005509	Molecular function	calcium ion binding
GO_0005515	Molecular function	protein binding

Gene name	S100A10
Protein name	Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11) Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (S100 calcium-binding protein A10)
Synonyms	CLP11 CAL1L ANX2LG
Description	FUNCTION: Because S100A10 induces the dimerization of ANXA2/p36, it may function as a regulator of protein phosphorylation in that the ANXA2 monomer is the preferred target (in vitro) of tyrosine-specific kinase.
Accessions	P60903 ENST00000368809.1 ENST00000368811.8 Q6FGE5

S100A10 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review